Chaudhry R, Goel V, Sawka C
Department of Public Health Sciences, Faculty of Medicine, University of Toronto, Ont.
CMAJ. 2001 Jan 23;164(2):183-8.
A number of studies have documented variation in treatment patterns by treatment setting or by region. In order to better understand how treatment setting might affect survival, we compared the survival outcomes of women with node-negative breast cancer who were initially treated at teaching hospitals with those of women initially treated at community hospitals.
We constructed a retrospective cohort consisting of a random sample of 938 cases, initially diagnosed in 1991, drawn from the Ontario Cancer Registry. Exposure was defined by the type of hospital in which the initial breast cancer surgery was performed. Outcomes were ascertained through follow-up of vital statistics.
The crude 5-year survival rate was 88.7% for women who had their initial surgery in a community hospital and 92.5% for women who had their initial surgery in a teaching hospital. Women in higher income neighbourhoods experienced better survival at 5 years regardless of which type of hospital they were treated in. Multivariate proportional hazards regression modelling demonstrated a 53% relative reduction in risk of death among women with tumours less than or equal to 20 mm in diameter who were treated at a teaching hospital (relative risk [RR] = 0.47, 95% confidence interval [CI] 0.23-0.96), whereas among those with larger tumours there was no demonstrated difference in survival (RR = 1.32, 95% CI 0.73-2.32). Other variables that were significant in the model were age at diagnosis, estrogen receptor status and the use of radiation therapy.
Women with node-negative breast cancer and tumours less than or equal to 20 mm in diameter who were initially seen at a teaching hospital had significantly better survival than women with similar tumours who were initially seen at a community hospital. Survival among women with larger tumours was not statistically significantly different for the 2 types of hospital.
多项研究记录了治疗模式在治疗机构或地区之间的差异。为了更好地理解治疗机构如何影响生存率,我们比较了初治于教学医院的淋巴结阴性乳腺癌女性患者与初治于社区医院的女性患者的生存结局。
我们构建了一个回顾性队列,该队列由从安大略癌症登记处抽取的938例1991年首次诊断的随机样本组成。暴露因素由首次进行乳腺癌手术的医院类型定义。通过生命统计随访确定结局。
在社区医院接受首次手术的女性患者的5年粗生存率为88.7%,在教学医院接受首次手术的女性患者为92.5%。无论在哪种类型的医院接受治疗,高收入社区的女性5年生存率更高。多变量比例风险回归模型显示,直径小于或等于20 mm的肿瘤患者在教学医院接受治疗时,死亡风险相对降低53%(相对风险[RR]=0.47,95%置信区间[CI]0.23 - 0.96),而肿瘤较大的患者在生存方面未显示出差异(RR = 1.32,95%CI 0.73 - 2.32)。模型中其他显著的变量为诊断时的年龄、雌激素受体状态和放疗的使用情况。
初诊于教学医院的直径小于或等于20 mm的淋巴结阴性乳腺癌女性患者的生存率显著高于初诊于社区医院的类似肿瘤女性患者。两种类型医院中肿瘤较大的女性患者的生存率在统计学上无显著差异。